news

22 cities are carrying out pilot projects, and the housing inspection sector has soared

2024-08-26

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

High-performing overseas institutional research stocks are exposed.

The Shanghai Composite Index fluctuated in a narrow range in the morning, and the micro-cap index rose by nearly 2.5%. Solid-state battery concepts continued to strengthen, consumer electronics concepts fluctuated and rose, folding screens led the gains, and western development concept stocks continued to be active; highways, monkeypox concepts, education, precious metals and other sectors led the decline.

National WaterThe stock hit the daily limit in early trading, after hitting the daily limit three times in the previous four days. On the news front, Guozhong Water announced last Friday that the company and its shareholder Pengxin Group were filed by the China Securities Regulatory Commission for suspected violations of information disclosure laws and regulations.

National Inspection Group, Jianke Co., Ltd., Shanghai JiankeHousing inspection concept stocks soared. On the news front, Dong Jianguo, Vice Minister of the Ministry of Housing and Urban-Rural Development, recently said that the three systems of housing physical examination, housing pension and housing insurance will be studied and established to build a long-term mechanism for housing safety management throughout the life cycle. Shanghai and 22 other cities are currently carrying out pilot projects.

New sharesN Xiaofang(Xiaofang Pharmaceutical) once rose by nearly 213% in early trading, triggering a temporary suspension. The company's products cover the digestive, skin and ophthalmic sub-areas, and the brand's various external medicine products - enema, glycerin enema, calamine lotion, zinc oxide ointment, salicylic acid ointment, iodine glycerin, furan nasal drops and other products have a leading market share.

The issue price of Xiaofang Pharmaceutical is 12.47 yuan per share, and the issue price-earnings ratio is 10.02 times. In terms of performance, Xiaofang Pharmaceutical will achieve operating income of 402 million yuan, 457 million yuan, and 472 million yuan from 2021 to 2023, respectively; and achieve net profit attributable to the parent of 126 million yuan, 175 million yuan, and 204 million yuan.

9 stocks were surveyed by more than 10 overseas institutions

According to the Securities Times Databao statistics, in the past 10 days, a total of 209 companies have been surveyed by institutions. In terms of the types of institutions surveyed, securities companies surveyed 197 companies, accounting for the largest proportion; fund companies surveyed 173 companies, ranking second; overseas institutions visited a total of 77 listed companies.

Among the overseas institutional research lists, 9 stocks have more than 10 research institutions;China Testing Technology Co., Ltd.The number of overseas institutions conducting research on this topic reached 70, attracting the most attention.

The company stated in the survey that in the field of construction and engineering products, the company actively responded to the impact of the downturn in the real estate industry and made timely strategic adjustments. After more than a year of operation, operating income turned from decline to increase and gross profit margin increased.

followed byJardine MathesonA total of 21 overseas institutions participated in the survey.

The company stated that its overseas revenue in the first half of 2024 decreased year-on-year, mainly due to the inventory of ventilators in the U.S. market channel, while there was little change in other overseas regions. Currently, inventory pressure in the U.S. market is gradually fading and will gradually begin to improve in the future.

18 overseas institutions

Research stocks have high performance growth

From the perspective of stock price performance, the stocks surveyed by overseas institutions have fallen by an average of 3.5% in the past 10 days; among them, the stocks with the highest stock price increases areMingyue Lenses, Kangtuo Medical, Huitian New Materialswait.

Moonlight LensesThe cumulative increase is 23.6%, and the stock price has performed the best. In the past 10 days, it has been surveyed by 7 overseas institutions. The company said that the overseas business used to account for a small proportion, and now it is trying to promote myopia defocus products overseas, especially in Southeast Asia where Chinese people gather; the overseas ToC business has been initially deployed in Indonesia, the Philippines, Vietnam, and Malaysia in Southeast Asia.

The stocks with the largest decline in the range includeWavelength Optoelectronics, Shanghai Jahwa, Googol Technology, Shennong Group, Junda Shares

In terms of performance, the stocks that have attracted attention from overseas institutions in the past 10 days have all released their first half performance reports or forecasts.China General Nuclear Power Group, Hikvision, Yunnan Yuntianhua, Tianshan AluminumThe net profit scale of each company ranks at the top, exceeding 2 billion yuan.

The performance of the 18 stocks surveyed by overseas institutions achieved significant growth in the first half of the year, all of which were profitable and had a year-on-year increase of more than 30%.Will Semiconductor, ZWSoft, Hekang New Energy, Xianhe SemiconductorThe net profits increased by 792.79%, 563.93%, 471.13% and 204.73% year-on-year respectively.